HYREZTIQ
The "HYREZTIQ" trademark, serial number 77889237 , was filed on 9th of December 2009 with a mark drawing code of 4000 and its transaction date is 77889237. Since 7th of June 2012, the document can be found in the M70 law office in the publication and issue section. The employee responsible is CARROLL, DORITT and the date it was published for opposition on 04/13/2010. The status of the trademark was checked last on 06/06/2012.
The "HYREZTIQ" trademark, serial number 85951392 , was filed on 5th of June 2013 with a mark drawing code of 4000 and its transaction date is 85951392. The attorney assigned is Heather McDonald, attorney docket number HYREZTIQ / U. Since 13th of January 2014, the document can be found in the N10 law office in the publication and issue section. The employee responsible is PRATER, JILL I and the date it was published for opposition on 10/15/2013. The status of the trademark was checked last on 12/10/2013.
The corresponded responsible for this trademark is HEATHER MCDONALD, located at PFIZER INC., 235 E 42ND ST, NEW YORK, NY 10017-5703.The state or country where the trademark was organized is NY by Pfizer Inc.. The legal entity type behing it is a Corporation, located at 235 East 42nd Street, New York, NY zip 10017.Other trademarks by this applicant: ACITEK, NETCAP, ELELYSO.
GOODS AND/OR SERVICES | |
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
---|---|
U.S. Class | 052 - Detergents and Soaps |
Class Status | 6 - Active |
Status Date | 06/14/2013 |
Primary Code | 005 |
Goods codes | |
GS0051 | Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use |
PROSECUTION HISTORY | ||||
Date | Description | Type | Code | |
---|---|---|---|---|
12/10/2013 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | E | NOAM | |
10/15/2013 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | E | NPUB - NOTICE OF PUBLICATION | |
10/15/2013 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
09/25/2013 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | E | NONP | |
09/03/2013 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
08/29/2013 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
06/14/2013 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | I - Incoming Correspondence | NWOS | |
06/08/2013 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.